Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04632849 · ClinicalTrials.gov registry record · NA
The Use of Libre to Improve Metabolic Control and Reduce Reliance on Medication
A NA study, sponsored by University of Virginia.
- Completed
- Registry status
- NA
- Development phase
- 17
- Enrollment target
NCT04632849 is a NA study that has completed, run by University of Virginia. The registered enrollment target is 17 participants.
The verdict
NCT04632849, a NA study, has completed, sponsored by University of Virginia.
- COMPLETED
- Registry status
- NA
- Development phase
- 17 participants
- Enrollment target
Study Summary
GEM (Glycemic Excursion Minimization) is a new lifestyle treatment for type 2 diabetes that aims to lower glucose levels after meals and snacks. This is different from the current lifestyle treatment, which is to lose weight. This study is trying to find out if people who are newly diagnosed with type 2 diabetes can use a continuous glucose monitor together with the GEM lifestyle to improve control of their diabetes. Study participants will follow the GEM lifestyle for 4 months (1 month of treatment and 3 months of maintenance) instead of seeking usual care (medications or weight loss programs) to lower blood glucose.
Interventions
- BEHAVIORAL GEM + CGM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2020-11-01 |
| Est. Completion | 2021-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04632849
The ClinicalTrials.gov registry entry for NCT04632849 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GEM + CGM is the first listed.
NCT04632849 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04632849 about?
NCT04632849 is a clinical study titled "The Use of Libre to Improve Metabolic Control and Reduce Reliance on Medication". GEM (Glycemic Excursion Minimization) is a new lifestyle treatment for type 2 diabetes that aims to lower glucose levels after meals and snacks. This is different from the current lifestyle treatment, which is to lose weight. This study is trying to find out if people who are newly diagnosed with ty...
What is the current status of trial NCT04632849?
This trial is currently completed. It is a NA study. The enrollment target is 17 participants. The study started on 2020-11-01. Estimated completion is 2021-09-01.
What interventions are being tested in trial NCT04632849?
The interventions under investigation include: GEM + CGM (BEHAVIORAL).
Who is sponsoring clinical trial NCT04632849?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.